ANEB OTC
Anebulo Pharmaceuticals, Inc.
1W: -1.5%
1M: +6.7%
3M: -13.0%
YTD: -71.7%
1Y: -86.7%
3Y: -90.2%
5Y: -95.4%
$0.32
+0.00 (+0.00%)
Weekly Expected Move ±12.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
ESG Scores — ANEB
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (19)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-Q | 52.8 | 71.0 | 65.5 | 63.1 | SEC ↗ |
| 2025-09-30 | 10-Q | 52.8 | 67.7 | 67.1 | 62.5 | SEC ↗ |
| 2025-06-30 | 10-K | 56.7 | 63.0 | 63.0 | 60.9 | SEC ↗ |
| 2025-03-31 | 10-Q | 57.0 | 69.0 | 63.6 | 63.2 | SEC ↗ |
| 2024-12-31 | 10-Q | 55.5 | 70.5 | 67.6 | 64.5 | SEC ↗ |
| 2024-09-30 | 10-Q | 50.5 | 67.2 | 64.8 | 60.8 | SEC ↗ |
| 2024-06-30 | 10-K | 54.3 | 63.0 | 62.1 | 59.8 | SEC ↗ |
| 2024-03-31 | 10-Q | 56.0 | 63.5 | 62.4 | 60.6 | SEC ↗ |
| 2023-12-31 | 10-Q | 58.1 | 64.0 | 62.9 | 61.7 | SEC ↗ |
| 2023-09-30 | 10-Q | 58.8 | 63.6 | 62.9 | 61.8 | SEC ↗ |
| 2023-06-30 | 10-K | 57.4 | 63.3 | 62.6 | 61.1 | SEC ↗ |
| 2023-03-31 | 10-Q | 54.9 | 61.2 | 63.6 | 59.9 | SEC ↗ |
| 2022-12-31 | 10-Q | 55.5 | 61.0 | 63.8 | 60.1 | SEC ↗ |
| 2022-09-30 | 10-Q | 55.9 | 62.1 | 63.6 | 60.6 | SEC ↗ |
| 2022-03-31 | 10-Q | 45.7 | 59.0 | 67.3 | 57.3 | SEC ↗ |
| 2021-12-31 | 10-Q | 46.1 | 59.9 | 66.2 | 57.4 | SEC ↗ |
| 2021-09-30 | 10-Q | 45.7 | 59.1 | 63.8 | 56.2 | SEC ↗ |
| 2021-06-30 | 10-K | 56.4 | 65.0 | 63.8 | 61.7 | SEC ↗ |
| 2021-03-31 | 10-Q | 59.7 | 68.2 | 67.0 | 65.0 | SEC ↗ |